zika virus vaccines

Oligonucleotide therapeutics breaking new ground – modified mRNA vaccines for ZIKA virus enabling rapid vaccine development for emerging disease

Messenger RNA was first used as a vector to express proteins in mice in 1990 (1), but has not gained nearly the same attention as DNA vectors, largely because most researchers consider mRNA expensive to produce as well as too fragile and difficult to work with. However, growing experience over the last 10 years has…